Tongle Yu

Director/Miembro de la Junta en

Jiangsu Highlight Equity Investment Management Co. Ltd.

57 años

16 relaciones

Health Technology

Consumer Services

Finance

Perfil

Tongle Yu is currently a Partner at Jiangsu Highlight Equity Investment Management Co. Ltd. Previously, he worked as a Non-Executive Director at Biosino Bio-Technology & Science, Inc. from 2013 to 2015.
He obtained his undergraduate degree from Fudan University.

Cargos activos de Tongle Yu

Empresas	Cargo	Inicio
Jiangsu Highlight Equity Investment Management Co. Ltd. Jiangsu Highlight Equity Investment Management Co. Ltd. Investment ManagersFinance Highlight Capital is an active asset manager that provides equity financing for early and growth stage capital requirements. The firm targets companies operating in the biopharmaceutical, medical technology and consumer health sectors.	Director/Miembro de la Junta	-

Todos los cargos activos de Tongle Yu

Antiguos cargos conocidos de Tongle Yu.

Empresas	Cargo	Fin
BIOSINO BIO-TECHNOLOGY AND SCIENCE INCORPORATION	Director/Miembro de la Junta	03/03/2015

Ver el detalle de la experiencia de Tongle Yu.

Formación de Tongle Yu.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Tongle Yu.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	3
Biosino Bio-Technology & Science, Inc. Biosino Bio-Technology & Science, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes in-vitro diagnostic reagent	Health Technology
Fudan University Fudan University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Jiangsu Highlight Equity Investment Management Co. Ltd. Jiangsu Highlight Equity Investment Management Co. Ltd. Investment ManagersFinance Highlight Capital is an active asset manager that provides equity financing for early and growth stage capital requirements. The firm targets companies operating in the biopharmaceutical, medical technology and consumer health sectors.	Finance